Cargando…

Aldosterone and Mineralocorticoid Receptor System in Cardiovascular Physiology and Pathophysiology

The mineralocorticoid hormone aldosterone (Aldo) has been intensively studied for its ability to influence both the physiology and pathophysiology of the cardiovascular system. Indeed, although research on Aldo actions for decades has mainly focused on its effects in the kidney, several lines of evi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cannavo, Alessandro, Bencivenga, Leonardo, Liccardo, Daniela, Elia, Andrea, Marzano, Federica, Gambino, Giuseppina, D'Amico, Maria Loreta, Perna, Claudia, Ferrara, Nicola, Rengo, Giuseppe, Paolocci, Nazareno
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6169243/ https://www.ncbi.nlm.nih.gov/pubmed/30327709 http://dx.doi.org/10.1155/2018/1204598

Ejemplares similares

Aldosterone Jeopardizes Myocardial Insulin and β-Adrenergic Receptor Signaling via G Protein-Coupled Receptor Kinase 2
por: Cannavo, Alessandro, et al.
Publicado: (2019)

Aging is associated with cardiac autonomic nerve fiber depletion and reduced cardiac and circulating BDNF levels
por: Elia, Andrea, et al.
Publicado: (2021)

Aldosterone and Mineralocorticoid Receptors—Physiology and Pathophysiology
por: Funder, John W.
Publicado: (2017)

Sphingosine Kinases and Sphingosine 1-Phosphate Receptors: Signaling and Actions in the Cardiovascular System
por: Cannavo, Alessandro, et al.
Publicado: (2017)

Genetic Catalytic Inactivation of GRK5 Impairs Cardiac Function in Mice Via Dysregulated P53 Levels
por: Marzano, Federica, et al.
Publicado: (2022)

Potential Bidirectional Relationship Between Periodontitis and Alzheimer’s Disease
por: Liccardo, Daniela, et al.
Publicado: (2020)

Why Do We Not Assess Sympathetic Nervous System Activity in Heart Failure Management: Might GRK2 Serve as a New Biomarker?
por: Bencivenga, Leonardo, et al.
Publicado: (2021)

Infective Endocarditis: A Focus on Oral Microbiota
por: Del Giudice, Carmela, et al.
Publicado: (2021)

Myocardial pathology induced by aldosterone is dependent on non-canonical activities of G protein-coupled receptor kinases
por: Cannavo, Alessandro, et al.
Publicado: (2016)

Periodontal Disease: A Risk Factor for Diabetes and Cardiovascular Disease
por: Liccardo, Daniela, et al.
Publicado: (2019)

Angiopoietins, Vascular Endothelial Growth Factors and Secretory Phospholipase A(2) in Ischemic and Non-Ischemic Heart Failure
por: Varricchi, Gilda, et al.
Publicado: (2020)

Aldosterone and the mineralocorticoid receptor in the cerebral circulation and stroke
por: Dinh, Quynh N, et al.
Publicado: (2012)

Modulation of Immunity and Inflammation by the Mineralocorticoid Receptor and Aldosterone
por: Muñoz-Durango, N., et al.
Publicado: (2015)

Role of Aldosterone and Mineralocorticoid Receptor in Cardiovascular Aging
por: Gorini, Stefania, et al.
Publicado: (2019)

Editorial: Smoldering Inflammation in Cardio-Immune-Metabolic Disorders
por: Varricchi, Gilda, et al.
Publicado: (2021)

The selective mineralocorticoid receptor modulator AZD9977 reveals differences in mineralocorticoid effects of aldosterone and fludrocortisone
por: Bamberg, Krister, et al.
Publicado: (2019)

Muscle Ultrasound as Imaging Domain of Frailty
por: Bencivenga, Leonardo, et al.
Publicado: (2022)

Targeting GRK5 for Treating Chronic Degenerative Diseases
por: Marzano, Federica, et al.
Publicado: (2021)

The Kidneys and Aldosterone/Mineralocorticoid Receptor System in Salt-Sensitive Hypertension
por: Shibata, Shigeru, et al.
Publicado: (2011)

Real-World Effectiveness of Mineralocorticoid Receptor Antagonists in Primary Aldosteronism
por: Tezuka, Yuta, et al.
Publicado: (2021)

Quality of Life of Primary Aldosteronism Patients by Mineralocorticoid Receptor Antagonists
por: Yoshida, Yuichi, et al.
Publicado: (2021)

Mineralocorticoid Receptors in the Pathophysiology of Vascular Inflammation and Atherosclerosis
por: Moss, Mary E., et al.
Publicado: (2015)

Roles of the Glucocorticoid and Mineralocorticoid Receptors in Skin Pathophysiology
por: Sevilla, Lisa M., et al.
Publicado: (2018)

Interaction of the Mineralocorticoid Receptor With RACK1 and Its Role in Aldosterone Signaling
por: Kuppusamy, Maniselvan, et al.
Publicado: (2017)

SAT-564 Effectiveness of Treatment with Mineralocorticoid Receptor Antagonistsin Primary Aldosteronism
por: Tezuka, Yuta, et al.
Publicado: (2020)

SAT-561 Effects of Mineralocorticoid Receptor Antagonists on Primary Aldosteronism Screening
por: Tezuka, Yuta, et al.
Publicado: (2020)

The Glucocorticoid Receptor is Required for Efficient Aldosterone-Induced Transcription by the Mineralocorticoid Receptor.
por: Johnson, Thomas A., et al.
Publicado: (2023)

Importance of Micromilieu for Pathophysiologic Mineralocorticoid Receptor Activity—When the Mineralocorticoid Receptor Resides in the Wrong Neighborhood
por: Griesler, Bruno, et al.
Publicado: (2022)

Endothelial Progenitor Cells and Rheumatoid Arthritis: Response to Endothelial Dysfunction and Clinical Evidences
por: Komici, Klara, et al.
Publicado: (2021)

Cardiac Hypertrophy and Fibrosis in the Metabolic Syndrome: A Role for Aldosterone and the Mineralocorticoid Receptor
por: Essick, Eric E., et al.
Publicado: (2011)

The Diuretic Torasemide Does Not Prevent Aldosterone-Mediated Mineralocorticoid Receptor Activation in Cardiomyocytes
por: Gravez, Basile, et al.
Publicado: (2013)

Mineralocorticoid Receptor and Aldosterone-Related Biomarkers of End-Organ Damage in Cardiometabolic Disease
por: Gorini, Stefania, et al.
Publicado: (2018)

PSUN68 Finerenone for Primary Aldosteronism: A Novel Mineralocorticoid Receptor Antagonist
por: Aurora, John, et al.
Publicado: (2022)

Spontaneous Remission of Primary Aldosteronism with Mineralocorticoid Receptor Antagonist Therapy: A Review
por: Mai, Xurong, et al.
Publicado: (2022)

The Management of Combined Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Particularly Complex Challenge, Especially in the Elderly
por: Bencivenga, Leonardo, et al.
Publicado: (2018)

The Aldosterone-Mineralocorticoid Receptor Pathway Exerts Anti-Inflammatory Effects in Endotoxin-Induced Uveitis
por: Bousquet, Elodie, et al.
Publicado: (2012)

Aldosterone Inhibits In Vitro Myogenesis by Increasing Intracellular Oxidative Stress via Mineralocorticoid Receptor
por: Lee, Jin Young, et al.
Publicado: (2021)

A Podcast Discussing Aldosterone and Mineralocorticoid Receptor Antagonists in 2021: A Paradigm Shift
por: Epstein, Murray
Publicado: (2022)

FRI164 The Glucocorticoid Receptor is Required for Efficient Aldosterone-induced Transcription by the Mineralocorticoid Receptor
por: Johnson, Thomas A, et al.
Publicado: (2023)

Elderly at time of COronaVIrus disease 2019 (COVID-19): possible role of immunosenescence and malnutrition
por: Bencivenga, Leonardo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8fgs09qmm3vu3cb0pbrmaaaa70